Likewise, in certain cancer types, including tumors of the breast, lung, and colon, high levels of CDK1 have also been associated with poor prognosis [43], while upregulation of CDKN3 has been underscored as an independent poor prognostic factor in ovarian cancer [44]. Here, CDKN3 is linked to breast neoplasm.